Bacterial Infections Archives - Page 2 of 28

APEKS-NP: Cefiderocol Non-Inferior to Meropenem for Nosocomial, Gram-Negative Pneumonia

By

November 20, 2020

Researchers compared the efficacy and safety of cefiderocol vs high-dose, extended-infusion meropenem for adults with nosocomial pneumonia.

GI Illness

Severity Score for Pediatric Shigellosis and Implications for Vaccine Trials

By

Bradley van Paridon

November 13, 2020

Study authors compared characteristics of moderate to severe diarrhea between children with culture positive Shigella and culture-negative, qPCR-attributable Shigella and derived a new clinical severity score.

General Infectious Disease

Delayed Meropenem-Vaborbactam for Gram-Negative Infections Increases Negative Clinical Outcomes

By

Marissa Purdy

November 12, 2020

Investigators evaluated the relationship between delay of meropenem and vaborbactam therapy in patients with gram-negative bacterial infections and negative clinical outcomes.

GI Illness

No Clinical Benefit With Double Anaerobic Therapy for Intra-Abdominal Infections

By

Sweta Gupta

November 11, 2020

Double anaerobic therapy with piperacillin/tazobactam plus metronidazole was compared to piperacillin/tazobactam alone to manage patients with intra-abdominal infections.

There are 3 important factors in the healthcare environment that can affect discrimination and, ultimately, disclosure: (1) whether staff make an effort to reduce stigma and discrimination associated with HIV; (2) the level of encouragement staff provide to promote HIV testing and disclosure, including partner and family referrals; and (3) the ability to provide or refer patients to proper counseling and offer support.14 In healthcare environments, discrimination can take subtle and dangerous forms, including avoidance of treatment by healthcare practitioners, use of excessive precautions, and the release of sensitive information to third parties, rather than encouragement of voluntary disclosure. Each of these actions undermines the patient-provider relationship and can lead to suboptimal care and avoidance of care.14

Nosocomial Infections

Elizabethkingia Infection in Healthcare Settings

By

Zahra Masoud

November 11, 2020

Study authors assessed the prevalence of Elizabethkingia, healthcare settings involved, positive culture sites, and mitigation measures to prevent outbreak.

Sepsis

Addition of Ticagrelor to Antibiotics Clears MSSA Bacteremia: A Case Study

By

Bradley van Paridon

November 9, 2020

The effect of ticagrelor in addition to cefazolin plus ertapenem for the clearance of S aureus bacteremia was assessed in a case study.

Respiratory

Appropriate Antimicrobial Therapy for A baumannii Lowers Mortality in Severely Ill Patients

By

Zahra Masoud

November 6, 2020

The effect of appropriate antimicrobial therapy on 14-day mortality in patients severely ill with Acinetobacter baumannii bacteremic pneumonia was assessed, taking risk factors, patient demographics, and clinical characteristics into account.

General Infectious Disease

Age and Previous Cardiac Surgery Increases Mortality Risk in Infective Endocarditis Surgery

By

Zahra Masoud

November 4, 2020

Study authors assessed the association between mortality and age, history of cardiac surgery, and other risk factors in patients undergoing surgery for infective endocarditis.

General Infectious Disease

Myeloperoxidase ANCA-Associated Vasculitis May Occur After Infection and Regress After Its Resolution

By

Amit Akirov, MD

November 4, 2020

Researchers performed a systematic review to identify cases of infection-induced antimyeloperoxidase ANCA-associated vasculitis.

Prevention

New Gastric Cancer Prevention Guidelines for Eradicating H pylori

By

Jessica Nye, PhD

November 4, 2020

A global consensus meeting was convened to go over current evidence and knowledge gaps and propose collaborative studies on population-wide screening and eradication of Helicobacter pylori for the prevention of gastric cancer (GC).